Literature DB >> 23600494

Significant association between asthma risk and the GSTM1 and GSTT1 deletion polymorphisms: an updated meta-analysis of case-control studies.

Siqiao Liang1, Xuan Wei, Chen Gong, Jinmei Wei, Zhangrong Chen, Xiaoli Chen, Zhibo Wang, Jingmin Deng.   

Abstract

Polymorphisms in GSTM1 and GSTT1 may be associated with asthma risk, yet several studies and meta-analyses have reported inconclusive results. Therefore, an updated meta-analysis was conducted. Literature searches were performed using the Pubmed, Embase and Web of Science databases until October 2012. Variant 'null' genotype was compared with wild-type 'present' in the pooled data. All statistical analyses were performed using STATA 11.0. A total of 26 case-control studies were suitable for inclusion in the meta-analysis. In the overall population, a significant association was found for both the GSTM1 (odds ratio (OR) = 1.452; 95% confidence interval (CI): 1.192-1.770) and GSTT1 polymorphism (OR = 1.792; 95% CI:1.293-2.483). For subgroup analysis by age, GSTM1 significantly increased risk for both children (OR = 1.368; 95% CI: 1.051-1.781) and adults (OR = 1.859; 95% CI: 1.183-2.921). For GSTT1, a significant association was only found in the adult population (OR = 2.312; 95%CI: 1.204-4.439). Based on subgroup analysis by ethnicity, a significant association for GSTM1 was found in Europe (OR = 1.303; 95% CI: 1.018-1.667), Africa (OR = 2.175; 95%CI: 1.560-3.031) and Latin America (OR = 2.265; 95%CI: 1.375-3.729). For GSTT1, significantly increased risk was found only for Asian (OR = 2.105; 95% CI: 1.101-4.025) and Russian (OR = 2.747; 95% CI: 1.071-7.046) populations. This meta-analysis provides evidence that GSTM1 and GSTT1 polymorphisms may be risk factors for asthma.
© 2013 The Authors. Respirology © 2013 Asian Pacific Society of Respirology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23600494     DOI: 10.1111/resp.12097

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  15 in total

1.  Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations.

Authors:  Ritesh Agarwal; Sahajal Dhooria; Ashutosh Nath Aggarwal; Venkata N Maturu; Inderpaul S Sehgal; Valliappan Muthu; Kuruswamy T Prasad; Lakshmikant B Yenge; Navneet Singh; Digambar Behera; Surinder K Jindal; Dheeraj Gupta; Thanagakunam Balamugesh; Ashish Bhalla; Dhruva Chaudhry; Sunil K Chhabra; Ramesh Chokhani; Vishal Chopra; Devendra S Dadhwal; George D'Souza; Mandeep Garg; Shailendra N Gaur; Bharat Gopal; Aloke G Ghoshal; Randeep Guleria; Krishna B Gupta; Indranil Haldar; Sanjay Jain; Nirmal K Jain; Vikram K Jain; Ashok K Janmeja; Surya Kant; Surender Kashyap; Gopi C Khilnani; Jai Kishan; Raj Kumar; Parvaiz A Koul; Ashok Mahashur; Amit K Mandal; Samir Malhotra; Sabir Mohammed; Prasanta R Mohapatra; Dharmesh Patel; Rajendra Prasad; Pallab Ray; Jai K Samaria; Potsangbam Sarat Singh; Honey Sawhney; Nusrat Shafiq; Navneet Sharma; Updesh Pal S Sidhu; Rupak Singla; Jagdish C Suri; Deepak Talwar; Subhash Varma
Journal:  Lung India       Date:  2015-04

2.  No association between GSTM1 and GSTT1 genetic polymorphisms and susceptibility to opium sap dependence.

Authors:  Khyber Saify; Mohammad Rashid Khalighinasab; Mostafa Saadat
Journal:  Mol Biol Res Commun       Date:  2016-03

3.  Phototherapy for neonatal hyperbilirubinemia and childhood eczema, rhinitis and wheeze.

Authors:  Elizabeth Huiwen Tham; Evelyn Xiu Ling Loo; Anne Goh; Oon Hoe Teoh; Fabian Yap; Kok Hian Tan; Keith M Godfrey; Hugo Van Bever; Bee Wah Lee; Yap Seng Chong; Lynette Pei-Chi Shek
Journal:  Pediatr Neonatol       Date:  2018-03-24       Impact factor: 2.083

4.  Peridinin Is an Exceptionally Potent and Membrane-Embedded Inhibitor of Bilayer Lipid Peroxidation.

Authors:  Hannah M S Haley; Adam G Hill; Alexander I Greenwood; Eric M Woerly; Chad M Rienstra; Martin D Burke
Journal:  J Am Chem Soc       Date:  2018-11-02       Impact factor: 15.419

5.  Variants in genes coding for glutathione S-transferases and asthma outcomes in children.

Authors:  Steve Turner; Ben Francis; Nuha Wani; Susanne Vijverberg; Maria Pino-Yanes; Somnath Mukhopadhyay; Roger Tavendale; Colin Palmer; Esteban G Burchard; Simon Kebede Merid; Erik Melén; Anke H Maitland-van der Zee; On Behalf Of The Pharmacogenomics In Childhood Asthma Consortium
Journal:  Pharmacogenomics       Date:  2018-05-22       Impact factor: 2.533

6.  Gender-dependent effect of GSTM1 genotype on childhood asthma associated with prenatal tobacco smoke exposure.

Authors:  Chih-Chiang Wu; Chia-Yu Ou; Jen-Chieh Chang; Te-Yao Hsu; Ho-Chang Kuo; Chieh-An Liu; Chih-Lu Wang; Chia-Ju Chuang; Hau Chuang; Hsiu-Mei Liang; Kuender D Yang
Journal:  Biomed Res Int       Date:  2014-09-18       Impact factor: 3.411

Review 7.  Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) null polymorphisms and the risk of hypertension: a meta-analysis.

Authors:  Beihai Ge; Yadong Song; Yi Zhang; Xiaowen Liu; Yuxiang Wen; Xiaomei Guo
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

8.  Polymorphisms of glutathione S-transferase and methylenetetrahydrofolate reductase genes in Moldavian patients with ulcerative colitis: Genotype-phenotype correlation.

Authors:  Alexander Varzari; Igor V Deyneko; Elena Tudor; Svetlana Turcan
Journal:  Meta Gene       Date:  2015-12-10

9.  Do Variants in GSTs Modify the Association between Traffic Air Pollution and Asthma in Adolescence?

Authors:  Gayan Bowatte; Caroline J Lodge; Adrian J Lowe; Bircan Erbas; Martine Dennekamp; Guy B Marks; Jennifer Perret; Jennie Hui; Matthias Wjst; Lyle C Gurrin; Katrina J Allen; Michael J Abramson; Melanie C Matheson; Shyamali C Dharmage
Journal:  Int J Mol Sci       Date:  2016-04-01       Impact factor: 5.923

10.  Circulating Human Eosinophils Share a Similar Transcriptional Profile in Asthma and Other Hypereosinophilic Disorders.

Authors:  Cindy Barnig; Ghada Alsaleh; Nicolas Jung; Doulaye Dembélé; Nicodème Paul; Anh Poirot; Béatrice Uring-Lambert; Philippe Georgel; Fréderic de Blay; Seiamak Bahram
Journal:  PLoS One       Date:  2015-11-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.